Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy.
Izzedine
Hassane
H
Department of Nephrology, Pitié-Salpêtrière Hospital, Paris, France. hassan.izzedine@psl.ap-hop-paris.fr
Launay-Vacher
Vincent
V
Ciroldi
Magali
M
Fardet
Laurence
L
Deray
Gilbert
G
D000368:Aged; D000369:Aged, 80 and over; D000437:Alcoholism; D003511:Cyclohexanols / Q000009:adverse effects*; D005199:Fanconi Anemia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride